Open AccessTreatment of Vaginal Candidosis with Natamycin and Effect of Treating the partner at the same time
Author(s) -
Buch Annette,
Christensen Else Skytte
Publication year - 1982
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.3109/00016348209156578
Subject(s) - medicine , natamycin , cure rate , placebo , vaginal disease , vagina , surgery , dermatology , alternative medicine , pathology
. Thirty‐three patients with vaginal candidosis were treated with natamycin vaginal tablets for 10 days and their partners were treated double‐blind with natamycin cream/ placebo cream. Follow‐up examinations were carried out one week after the treatment was discontinued and again about one month later. The cure rate in patients having actively treated partners was 94%, not differing significantly from the cure rate of 88% in patients whose partners had been treated with placebo. One month after the treatment there was a high recurrence/re‐infection rate, about 30% in both groups. Thus, treating the partners of patients with vaginal candidosis has no influence upon the therapeutic outcome or recurrence rate. The recurrence is presumably due to re‐infection from the patient herself.